New hair loss drug enters human trials
Disease control
Recruiting now
This study tests a new drug called OLX72021 in healthy men with mild to moderate male pattern baldness. The goal is to see if it is safe and can increase hair count. Participants will receive multiple injections of the drug or a placebo over several months.
Phase: PHASE1, PHASE2 • Sponsor: Olix Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 09:31 UTC